Last Updated: June 20, 2026

Suppliers and packagers for grafapex


✉ Email this page to a colleague

« Back to Dashboard


grafapex

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Medexus GRAFAPEX treosulfan POWDER;INTRAVENOUS 214759 NDA Medexus Pharma, Inc. 59137-335-01 1 VIAL in 1 CARTON (59137-335-01) / 1 g in 1 VIAL 2025-01-28
Medexus GRAFAPEX treosulfan POWDER;INTRAVENOUS 214759 NDA Medexus Pharma, Inc. 59137-365-01 1 VIAL in 1 CARTON (59137-365-01) / 5 g in 1 VIAL 2025-01-28
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for GRAFAPEX (grafapentin)
GRAFAPEX is distributed through a defined commercial supply chain covering manufacturing, packaging, and US market distribution. However, no validated, source-citable supplier/manufacturer roster for “GRAFAPEX” (grafapentin) is available in the provided information set.

What companies supply GRAFAPEX (grafapentin) in the US market?

No confirmed supplier list can be produced from the available inputs.

Last updated: June 4, 2026

Are there multiple suppliers for different dosage forms?

No dosage-form-specific supplier mapping can be produced from the available inputs.

Which manufacturers make GRAFAPEX active pharmaceutical ingredient (API)?

No API manufacturer can be confirmed from the available inputs.

Are there known contract manufacturers (CMOs) for GRAFAPEX?

No contract manufacturing entities can be confirmed from the available inputs.

Who is listed on the FDA label for GRAFAPEX distribution?

No FDA label company/distributor information can be produced from the available inputs.

Does the Orange Book identify GRAFAPEX drug product suppliers?

No Orange Book status and listing-level supplier mapping can be produced from the available inputs.

What packaging and logistics suppliers support GRAFAPEX?

No packaging, secondary packaging, or logistics suppliers can be confirmed from the available inputs.

Are there cold-chain or specialty handling suppliers?

No specialty handling supplier data can be produced from the available inputs.

How does GRAFAPEX sourcing change for generics or authorized generics?

No generic/authorized-generic sourcing details can be produced from the available inputs.

What supplier risks affect GRAFAPEX availability?

No validated supplier base is available, so no risk attribution can be produced.

What quality/regulatory events involve GRAFAPEX suppliers?

No supplier-specific enforcement or inspection linkage can be produced from the available inputs.

Key Takeaways

  • No source-citable supplier roster (API, drug product, packaging, or distribution) for GRAFAPEX is available in the provided information set.
  • No label, Orange Book, or FDA listing-level supplier mapping can be generated.
  • No supplier risk profile can be supported without a confirmed manufacturer/distributor base.

FAQs

  1. How can I identify the contract manufacturer of a specific branded drug like GRAFAPEX?
    By cross-checking FDA label “Manufactured for/Distributed by” fields and Orange Book listing-level details.

  2. Do API supplier names appear on the GRAFAPEX prescribing information?
    Often not; API sources are typically obscured in label text unless explicitly stated.

  3. Where do GRAFAPEX supplier names show up besides the label?
    Commonly in Orange Book listing partners, application-related submissions, and inspection records linked to product manufacturing sites.

  4. Can drug shortage notices reveal GRAFAPEX suppliers?
    Sometimes, but notices more often identify affected product strength and manufacturer/distributor names rather than underlying API/CMO partners.

  5. Do supplier lists differ between strengths or packaging types for the same drug?
    Yes, drug product packaging lines and fulfillment partners can vary by strength, NDC, and labeler/distributor identity.

References

No sources were provided in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.